Iwasaki, Masaharu

Profile

Dr. Masaharu Iwasaki received his Ph.D. degree from Kyushu University for his work on viral RNA synthesis and virion assembly of measles virus in 2010, and graduated from Kyushu University School of Medicine in 2012 (MD-PhD program). Thereafter he worked as Research Associate (2012), Senior Research Associate (2015), and Staff Scientist (2017) at The Scripps Research Institute where he started studies on molecular mechanisms of arenavirus multiplication. He was appointed to the current position in 2018.

Publication

  • (1) Phenothiazines inhibit SARS-CoV-2 cell entry via a blockade of spike protein binding to neuropilin-1. Hashizume M. et al., Antiviral Res. (2023) 209:105481.
  • (2) The Pan-ErbB tyrosine kinase inhibitor afatinib inhibits multiple steps of the mammarenavirus life cycle. Mizuma K. et al., Virology (2022) 576:83-95.
  • (3) A small stem-loop-forming region within the 3′-UTR of a non-polyadenylated LCMV mRNA promotes translation. Hashizume M. et al., J Biol Chem. (2022) 298:101576.
  • (4) Population-Specific ACE2 Single-Nucleotide Polymorphisms Have Limited Impact on SARS-CoV-2 Infectivity In Vitro. Hashizume M. et al., Viruses (2021) 13:E67.
  • (5) A Lassa Virus Live-Attenuated Vaccine Candidate Based on Rearrangement of the Intergenic Region. Cai Y. et al., mBio (2020) 11:e00186-20.

Lab

Abe, Ryuichiro

International Research Center for Infectious Diseases

Laboratory of Bacterial Pathogenesis

Akira, Shizuo

Division of Host Defense

Department of Host Defense

Arase, Hisashi

Division of Host Defense

Department of Immunochemistry

Ebina, Hirotaka

BIKEN Innovative Vaccine Research Alliance Laboratories

Virus Vaccine Group

Hara, Eiji

Division of Cellular and Molecular Biology

Department of Molecular Microbiology

Horiguchi, Yasuhiko

Division of Infectious Disease

Department of Molecular Bacteriology

Horii, Toshihiro

Endowed Chair

Department of Malaria Vaccine Development

Iida, Tetsuya

Research Center for Infectious Disease Control

Department of Bacterial Infections

Ikawa, Masahito

Bioinformatics Center

Department of Experimental Genome Research

Ishitani, Tohru

Division of Cellular and Molecular Biology

Department of Homeostatic Regulation

Iwanaga, Shiroh

Research Center for Infectious Disease Control

Department of Molecular Protozoology

Kobayashi, Takeshi

Research Center for Infectious Disease Control

Department of Virology

Kotani, Ai

Division of Cellular and Molecular Biology

Department of Regulation of Infectious Cancer

Matsuura, Yoshiharu

Research Center for Infectious Disease Control

Laboratory of Virus Control

Murakami, Yoshiko

Division of Host Defense

Laboratory of Immunoglycobiology

Nakamura, Shota

Bioinformatics Center

Department of Infection Metagenomics

Shioda, Tatsuo

Division of Infectious Disease

Department of Viral Infections

Standley, Daron

Bioinformatics Center

Department of Genome Informatics

Suzuki, Kazuhiro

Division of Host Defense

Department of Immune Response Dynamics

Takakura, Nobuyuki

Division of Cellular and Molecular Biology

Department of Signal Transduction

Tsukamoto, Kentaro

International Research Center for Infectious Diseases

Laboratory of Bacterial Zoonoses

Watanabe, Tokiko

Division of Infectious Disease

Department of Molecular Virology

Yamamoto, Masahiro

Division of Infectious Disease

Department of Immunoparasitology

Yamasaki, Sho

Division of Host Defense

Department of Molecular Immunology

Yoshioka, Yasuo

BIKEN Innovative Vaccine Research Alliance Laboratories

Vaccine Creation Group